Warrants (Details) |
9 Months Ended |
---|---|
Mar. 31, 2019
$ / shares
shares
| |
Exercise Price | $ / shares | $ 0.15 |
Warrants [Member] | |
Outstanding at June 30, 2018 | 1,405,000 |
Exercised in 2019 | (400,000) |
Expired | |
Outstanding December 31, 2018 | 1,005,000 |
Warrants [Member] | $0.15 [Member] | |
Exercise Price | $ / shares | $ 0.15 |
Outstanding at June 30, 2018 | 500,000 |
Exercised in 2019 | |
Expired | |
Outstanding December 31, 2018 | 500,000 |
Warrants [Member] | $0.20 [Member] | |
Exercise Price | $ / shares | $ 0.20 |
Outstanding at June 30, 2018 | 105,000 |
Exercised in 2019 | |
Expired | |
Outstanding December 31, 2018 | 105,000 |
Warrants [Member] | $0.30 [Member] | |
Exercise Price | $ / shares | $ 0.30 |
Outstanding at June 30, 2018 | 500,000 |
Exercised in 2019 | (400,000) |
Expired | |
Outstanding December 31, 2018 | 100,000 |
Warrants [Member] | $0.75 [Member] | |
Exercise Price | $ / shares | $ 0.75 |
Outstanding at June 30, 2018 | 300,000 |
Exercised in 2019 | |
Expired | |
Outstanding December 31, 2018 | 300,000 |
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|